Which International Patient Safety Goal addresses miscommunication in a child who had an acute asthma exacerbation during handoff and was later found to have a peanut allergy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

International Patient Safety Goal: Decrease Mistakes Due to Miscommunication

The correct answer is C: Decrease mistakes due to miscommunication. This case directly exemplifies a communication failure during handover where critical allergy information was not effectively transmitted, placing the child at risk for fatal anaphylaxis from inadvertent peanut exposure during acute asthma management 1, 2.

Why This is a Communication Safety Issue

The handover period represents the most dangerous communication transition in healthcare where critical allergy information must be accurately transmitted 1, 2. In this scenario:

  • The peanut allergy was discovered by the nurse during handover, indicating it was not properly communicated by the transferring team 1
  • Children with concurrent asthma and peanut allergy face compounded risk for fatal food-induced anaphylaxis, as asthma is the strongest risk factor for fatal food-induced anaphylaxis 1, 2
  • Poor communication contributes to 24.0% of patient safety incidents (IQR 12.0% to 46.8%), and when it is the sole cause, accounts for 13.2% of incidents 3
  • Communication failures are a major cause of medical errors, though not necessarily the majority as commonly claimed 4, 3

Critical Communication Elements That Failed

The following allergy information must be communicated during every handover 2:

  • Specific allergen identification (peanut allergy was not communicated) 2
  • Emergency medication availability (epinephrine autoinjector location) 1
  • Asthma control status (particularly critical given the acute exacerbation) 1
  • Previous reaction severity (to assess anaphylaxis risk) 1

Immediate Actions Required After Discovery

Upon discovering the peanut allergy during handover, the provider must 2:

  • Document allergy prominently in all systems with clear visual alerts 2
  • Verify two epinephrine autoinjectors are immediately accessible 1, 2
  • Review all current medications for peanut-derived ingredients or cross-contamination risk 2
  • Communicate to dietary services with strict avoidance orders and cross-contamination precautions 2
  • Optimize asthma control, as respiratory symptoms may mask early anaphylaxis 1, 2

Why the Other Options Are Incorrect

Option A (Preoperative Surgical Checklist) is not applicable because this case involves medical management of acute asthma, not a surgical procedure 1.

Option B (Identify patient correctly by using two identifiers) addresses patient identification errors, not communication failures about known allergies during handover 1. The patient's identity was not in question—the problem was that critical allergy information was not transmitted 1, 2.

Common Pitfalls in Allergy Communication

  • Never assume allergy information has been communicated during handover—always verify directly 1
  • Asthma exacerbation itself can mask early anaphylaxis symptoms, delaying recognition and treatment 2
  • Delayed epinephrine administration has been implicated in contributing to fatalities from anaphylaxis, often because allergy information was not effectively communicated 2
  • Oral tingling or mild symptoms can rapidly progress to life-threatening anaphylaxis within minutes 2
  • Biphasic reactions occur in 1-20% of cases, requiring 4-6 hours observation even after initial symptom resolution 2

Documentation Standards to Prevent Future Errors

Allergy documentation must include 2:

  • Specific allergen name (peanut, not just "nuts") 2
  • Reaction type and severity (urticaria, anaphylaxis, etc.) 2
  • Time course (immediate vs. delayed) 2
  • Confirmatory testing results if available 2

References

Guideline

Decreasing Mistakes Due to Miscommunication in Patient Care

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Peanut Allergy in Acute Asthma Exacerbation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the standard of communication in medical settings?
What International Patient Safety Goal applies to a patient with a history of asthma and a peanut allergy who experiences an acute asthma exacerbation during handover?
How to manage a patient with excessive talking?
What are the consequences of communication errors in medicine?
What International Patient Safety Goal is most relevant when a child with a peanut allergy experiences an acute asthma exacerbation?
What is anabolic resistance in cirrhosis and how should it be managed?
For a 15‑month‑old child in the emergency department with a newly discovered Do‑Not‑Resuscitate order from another facility, how should the DNR be verified before being honored?
What is the most likely cause and appropriate initial management for an adult without chronic liver disease who has a low absolute lymphocyte count, elevated absolute monocyte count, mildly elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT), and a borderline‑elevated procalcitonin?
Should a primary‑care physician or an otolaryngology‑head‑and‑neck surgeon refer a patient for Inspire hypoglossal‑nerve stimulation?
A patient invited to a clinical trial for a new drug worries about being assigned to the placebo arm; the physician reassures that standard therapy will continue. Which ethical principle is most relevant? A. Beneficence B. Non‑maleficence C. Autonomy D. Justice
In a patient with moderate-to-severe obstructive sleep apnea who is failing CPAP therapy, should primary care refer first to a sleep‑medicine specialist for diagnostic polysomnography and CPAP management, or directly to an otolaryngology‑head‑and‑neck surgeon for evaluation of hypoglossal‑nerve stimulation (Inspire)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.